Both in Pharmaceuticals
Assembly Biosciences vs Prothena
Over the past year ASMB returned −35.2% and PRTA returned −21.2%; their daily moves had a correlation of 0.40.
ASMB −35.2% PRTA −21.2%Growth of $1, one year, split-adjusted
| Metric | ASMB | PRTA |
|---|---|---|
| Price | $20.13 | $8.47 |
| Market cap | $409.9M | $434.8M |
| Today | −3.50% | −4.62% |
| 1 month | −12.4% | −0.8% |
| 6 months | −26.5% | −20.4% |
| Year to date | −40.8% | −11.3% |
| 1 year | −35.0% | −20.5% |
| Revenue growth (YoY) | +38.9% | −77.1% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −28.8% | −1839.9% |
| P/E (TTM) | — | — |
| Price / sales | 5.5× | 8.0× |
| Net cash | $320.4M | $288.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.4% | 46.5% |
| Short % of float | 28.0% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).